Genome-Wide Analysis Reveals the Secondary Metabolome in Streptomyces kanasensis ZX01

ZX01 produces some antibiotics and a glycoprotein with antiviral activity. To further evaluate its biosynthetic potential, here we sequenced the 7,026,279 bp draft genome of ZX01 and analyzed all identifiable secondary gene clusters for controlling natural products. More than 60 putative clusters we...

Full description

Saved in:
Bibliographic Details
Published in:Genes 2017-11, Vol.8 (12), p.346
Main Authors: Zhang, Guoqiang, Yu, Dailin, Sang, Bu, Feng, Juntao, Han, Lirong, Zhang, Xing
Format: Article
Language:English
Subjects:
Antibiotics
Antiviral activity
Gene clusters
Genomes
Genomic analysis
Glycoproteins
Natural products
Purification
Streptomyces
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:ZX01 produces some antibiotics and a glycoprotein with antiviral activity. To further evaluate its biosynthetic potential, here we sequenced the 7,026,279 bp draft genome of ZX01 and analyzed all identifiable secondary gene clusters for controlling natural products. More than 60 putative clusters were found in ZX01, the majority of these biosynthetic loci are novel. In addition, the regulators for secondary metabolism in ZX01 were abundant. The global regulator not only controls biosynthesis of some antibiotics, but also enhances production of glycoprotein GP-1 with antiviral activity. This study importantly reveals the powerful interplay between genomic analysis and studies of traditional natural product purification/production increasing.
ISSN:2073-4425
2073-4425
DOI:10.3390/genes8120346